Point72 Asset Management, L.P. - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.8%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,538,324
-74.8%
662,529
-61.8%
0.01%
-75.9%
Q2 2023$18,007,505
+65.5%
1,736,500
+29.1%
0.05%
+58.8%
Q1 2023$10,877,814
-61.3%
1,344,600
-24.6%
0.03%
-64.2%
Q4 2022$28,075,950
-3.8%
1,782,600
-3.8%
0.10%
-18.8%
Q3 2022$29,170,000
+20.5%
1,853,251
+6.9%
0.12%
+14.7%
Q2 2022$24,205,000
-38.3%
1,733,900
-23.9%
0.10%
-34.6%
Q1 2022$39,257,000
+320.0%
2,277,100
+254.2%
0.16%
+321.6%
Q4 2021$9,348,000
+32.7%
642,900
+64.3%
0.04%
+19.4%
Q3 2021$7,043,000
-16.2%
391,300
-18.2%
0.03%
-18.4%
Q2 2021$8,404,000
+1.7%
478,600
+46.0%
0.04%
-2.6%
Q1 2021$8,261,000
+53.3%
327,800
+21.4%
0.04%
+77.3%
Q2 2018$5,390,000
-57.9%
269,922
-63.0%
0.02%
-58.5%
Q1 2018$12,796,000
-34.5%
730,374
-7.8%
0.05%
-36.9%
Q4 2017$19,531,000
-15.2%
792,000
-11.2%
0.08%
-18.4%
Q3 2017$23,030,000
-1.5%
892,298
+3.5%
0.10%
-21.4%
Q2 2017$23,388,000
+70.5%
862,402
+87.5%
0.13%
+72.4%
Q1 2017$13,715,000459,9160.08%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 441,000$833,0002.78%
MFN Partners Management, LP 4,000,000$7,560,0001.56%
Endurant Capital Management LP 2,055,069$3,884,0001.22%
Broadfin Capital, LLC 1,888,039$3,568,0000.48%
Aisling Capital Management LP 634,455$1,199,0000.46%
EcoR1 Capital, LLC 2,087,312$3,945,0000.36%
Sofinnova Investments, Inc. 1,911,573$3,613,0000.26%
Alambic Investment Management, L.P. 115,036$217,0000.18%
Parkman Healthcare Partners LLC 225,000$425,0000.12%
Rock Springs Capital Management LP 1,600,000$3,024,0000.10%
View complete list of ACLARIS THERAPEUTICS INC shareholders